GeneDx Holdings Corp. (WGS)

GeneDx Holdings Corp. is trading at $79.13, up 3.66% on the session. The 50 day average sits at $64.50 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 62.7, which reads as strong, and MACD is bullish crossover. Volume is below average.

The nearest support is around $58.78 with resistance near $79.38, so that band frames the current range. Average daily movement is roughly $5.20, or about 6.6% of the share price, which is what any stop placement has to allow for. The overall health score of 66 out of 100 combines a trend score of 75, momentum of 88 and a risk score of 22.

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.